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in pregnancy is changing and differs between countries. It is
believed that Rheumatic heart disease is more common than
other heart diseases in India.We found in our registry of antenatal
mothers that RHD is second most common heart disease.
Methods: We registered 1,125 antenatal mothers in outpatient
department who are referred to undergo cardiac evaluation from
Jan 2014 to June 2014. All were asymptomatic except few who had
NYHA class II symptoms. Echocardiogram done and those with
heart disease are classified.
Results:
Category Number (total 1125) Percentage%
RHD-total 17 1.511
RHD-MS 13 1.155
RHD MS/MR 1 0.088
RHD-S/P IV1VR 2 0.177
RHD S/P CIVIC 1 0.088
Congenital total 24 2.133
ASD-OS 6 0.533
ASD dIVC 1 0.088
VSD 2 0.177
PDA 0 0
S/P ASD closure 5 0.444
S/P VSD closure 1 0.088
S/P PDA ligation 2 0.177
MVP eAML 3 0.266
BCAV-AR 1 0.088
BCAV -AR 2 0.177
S /P ICR for DORV VSD PS 1 0.088




43(3.8%) out of 1,125 had heart disease. Among heart diseases,
the relative proportions were CHD 56%, RHD 40%, CAD and CMY
2%. Median age was 23 years 151(13.42%) .14 yrs was the youngest
age and 47 yrs was the oldest age . Among them , primi
627(55.73%), second gravida 448(39.82%), third gravida 50(4.44%).
Conclusions: There has been varied reports about the incidence
and prevalence of RHD in Indian population .However among
heart disease complicating pregnancy from we have found a
definite decline in the prevalence of RHD while CHD has surged
ahead over RHD. This may be attributable to the changing socio-
economic, environmental factors and reduction in family size.
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Background: Routine use of thrombolytic therapy in hemody-
namically stable patients with sub massive pulmonary embolism
is controversial.
Rationale: To observe the safety & efficacy of thrombolytic ther-
apy in acute pulmonary embolism patients with normal blood
pressure and right ventricular dysfunction.
Methods: In this study, 130 patients with sub-massive pulmonary
embolism who had right ventricular (RV) dysfunction, were
included and treated with thrombolytic therapy.
Results: Mean age of our study patients was 43 +/- 14. 9 years.
Fifty-three (41%) patients in our study were within forty years of
age. Hundredeeight (83%) patients had clinical improvement in
NYHA class and it was statistically significant (p<0.001). Both RV
dysfunction and pulmonary artery systolic pressure (PASP)
improved significantly following thrombolytic therapy from
baseline (mean PASP 49 mm of Hg vs 28 mm of Hg; p¼ 0.01; 95% CI
¼ -13 to e 56). Twelve (9%) patients died and two patients (1.5%)
developed intra cerebral haemorrhage.
Conclusion: Thrombolytic therapy is helpful in improving clinical
course following sub-massive acute pulmonary embolism.
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Objective: This studywas planned to compare the efficacy of bolus
regimens of tenecteplase and 24 hours infusion of streptokinase
in acute pulmonary embolism in resource poor setting.
Methods: Design: It was a comparative study. Setting: It was done
in a single tertiary cardiac care centre. Patients: One-hundred
patients with acute pulmonary embolism were included and
divided according to their treatment received. Interventions:
Twenty-five patients received injection Tenecteplase as a single
bolus injection according to their body weight. Seventy-five pa-
tients received infusion of Streptokinase over 24-48 hours. Main
outcome measures: The outcome in this study was to determine
the reduction of RV dysfunction and/ or PASP seen at echocardi-
ography performed 24 hours after treatment given.
Results: Fifty-six percent patients in our study were within forty
years of age. Forty-three percent of total patients had normal
blood pressure in presence of right ventricular dysfunction. Pul-
monary artery systolic pressure was improved separately in both
the study groups of patients from baseline at 24 hours or at 7th
day, but was comparable among the TNK and STK group of pa-
tients. Mean duration of stay in ICU was significantly less in TNK
group (2.2 +/- 0.8 vs 3.2 +/- 1.3 days; p¼0.04) though the cost of
therapy was three times more than STK group (USD 800 vs USD
275; p¼0.01).
Conclusion: These results suggest that a 24-h infusion regimen of
streptokinase is as effective as bolus tenecteplase in the treatment
of patients with acute pulmonary embolism in countries with
limited resources.
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Background: Prevalence of acute pulmonary embolism is
increasing in general population especially in old population.
Prevalence of acute pulmonary embolism in young adults is
unknown.The objective of this study was to assess the prevalence
of acute pulmonary embolism in young (<40 years) population and
to compare the clinical presentation and the therapeutic benefit in
regards to age at presentation. Settings: A single tertiary cardiac
care centre.
Methods: In this study, among 202 patients enrolled, 97 & 105
patients were admitted as young & old patient, respectively. The
clinical presentation and course after therapy among them were
observed and compared.
Results: forty-eight percent of our study population belongs to <40
years of age. There were no significant differences seen in func-
tional class, hypotension, electrocardiographic & echocardio-
graphic features based on age difference. Clinical improvement
after treatment (68% vs 78%, p¼0.42) and in hospital death (10% vs
16%, p¼0.36) was non-significantly more in older than in young
patients. Though the incidence of minor bleeding (14% vs 11%,
p¼0.68) was non-significantly higher in older group of patients but
two patients in this group had intra-cerebral bleed following
thrombolytic therapy.
Conclusion: As there were no significant differences in the clinical
presentation, therapeutic benefit, and course after therapy and
complication, therefore, age should not influence the decision to
treat pulmonary embolism patients especially with thrombolytic
agents though caution should be taken while treating older
patients.
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Background: In hypothyroidism there is reduced production of
thyroid hormone which leads to characteristic cardiovascular
clinical features including sinus bradycardia, diastolic hyperten-
sion, pericardial effusion, dyslipidemia, cardiomyopathy,
congestive heart failure, etc. So far our knowledge goes this study
is first of its kind in Upper Assam.
Methods: This study was undertaken in 79 patients with hypo-
thyroidism, diagnosed on the basis of clinical features and thyroid
function tests and were taken up for the study after considering
the inclusion and exclusion criteria. This was a hospital based
observational study.
Results: 79 patients with hypothyroidism were included in the
study. The mean age of patients was 42.59 ± 14.15 years and
74.68% were females. The most common symptoms of hypo-
thyroidism in the patients were fatigue (59.49%), followed by
lethargy (55.70%). Cardiovascular involvement was present in
68.35% patients. The most common symptom of cardiovascular
involvement was effort intolerance (35.44%) followed by chest
pain (21.53%). Diastolic hypertension (34.18%) and sinus brady-
cardia (25.32%) were the most common cardiovascular signs in
the patients. Pearson correlation showed a positive correlation
between the number of symptoms in the patients and the serum
TSH level. Linear regression analysis also showed a significant
correlation between serum TSH and serum levels of total
cholesterol, LDL cholesterol and triglycerides (p value <0.05). The
most common ECG abnormality was sinus bradycardia and the
most common abnormality on Echocardiography was LV dia-
stolic dysfunction (34.18%). Holter monitoring revealed QT pro-
longation with evidence of non-sustained ventricular tachycardia
in 1 patient (1.27%), and Tread mill test was positive in 1 patient
(1.27%).
Conclusion: Cardiovascular manifestations are common in hy-
pothyroid patients which may lead to serious life threatening
arrhythymias and could gradually progress to preventable overt
heart failure.
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Background: Pulmonary embolism (PE) remains a medical emer-
gency, in massive pulmonary embolism and consequent right
ventricular failure, where restoration of pulmonary arterial flow is
urgently required, prompt therapeutic intervention is imperative.
Thrombolytic therapy has a potential to produce quick throm-
bolysis, improve hemodynamic instability and eliminate the
venous thrombi.Despite the approval of streptokinase, urokinase,
alteplase and tenecteplase for thromolysis in PE, the efficacy of
these thromolytics remain unclear due to the high mortality
associated with this condition.
Methods and Results: The 120 cases admitted with suspected
pulmonary embolism, only 68% (96) patients were thrombolysed,
rest 32% (44) were not thrombolysed due to old age , embolisation
in smaller lobar vessels and affordability of the patients. Total
enrolled patients were 105 males and 35 females of which 72
males and 24 females were thrombolysed. The presenting symp-
toms of dyspnoea, chest pain, hemoptysis and syncope were
found in 140(100%), 7 (5%), 0(0%) and 28 (20%) patients
respectively.
According to Well’s score for pretest probability of pulmonary
embolism, 5 % patients had high probability (Well’s score>6), 55%
patients had moderate probability (Well’s score between 2 and 6)
and 40% patient had low probability (Well’s score<2). The diag-
nosis of pulmonary embolism could be confirmed only in 8% pa-
tients using CT pulmonary angiography. In others, pulmonary
embolism was the most likely diagnosis based on Well’s score,
abnormal X-ray findings and evidence of right ventricular wall
stress on 2D-echocardiography.
The signs of right heart failure documented were raised jugular
venous pressure (46%), hepatomegaly (3%) and pleural effusion
(5%). The ECG findings included S1Q3T3 pattern (60%), right
bundle branch block (15%), and ST-T changes (25%).
The baseline echocardiography findings included evidence of
thrombus in pulomonary artery (15%), right atrium (5%), dilated
right ventricle (95%) and tricuspid regurgitation (55%).
In our study the efficacy of the thrombolytic agents used and the
complications associated with them did not show any significant
discrepancies. The two hour regimen of streptokinase which was
used in patients showed to be quite effective as well.
Conclusion: Because of the high cost and serious bleeding com-
plications that may arise with thrombolytic therapy, thrombolytic
treatment should be reserved for patients with massive PE
complicated by severe haemodynamic compromise.
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